KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Total Liabilities (2016 - 2025)

Bausch Health Companies (BHC) has disclosed Total Liabilities for 17 consecutive years, with $26.0 billion as the latest value for Q4 2025.

  • Quarterly Total Liabilities fell 3.19% to $26.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $26.0 billion through Dec 2025, down 3.19% year-over-year, with the annual reading at $26.0 billion for FY2025, 3.19% down from the prior year.
  • Total Liabilities hit $26.0 billion in Q4 2025 for Bausch Health Companies, down from $26.5 billion in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $30.7 billion in Q2 2021 to a low of $25.2 billion in Q2 2023.
  • Historically, Total Liabilities has averaged $27.3 billion across 5 years, with a median of $27.0 billion in 2024.
  • Biggest YoY gain for Total Liabilities was 7.89% in 2023; the steepest drop was 13.45% in 2023.
  • Year by year, Total Liabilities stood at $29.2 billion in 2021, then fell by 13.03% to $25.4 billion in 2022, then increased by 7.89% to $27.4 billion in 2023, then decreased by 2.14% to $26.8 billion in 2024, then dropped by 3.19% to $26.0 billion in 2025.
  • Business Quant data shows Total Liabilities for BHC at $26.0 billion in Q4 2025, $26.5 billion in Q3 2025, and $27.1 billion in Q2 2025.